Article

Androgen deprivation therapy and dose-escalated radiotherapy for intermediate- and high-risk prostate cancer: Sign of changing times?

JAMA Oncology
DOI: 10.1001/jamaoncol.2016.3987
1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Dalela, D., Karabon, P., & Abdollah, F. (2017, February 1). Androgen deprivation therapy and dose-escalated radiotherapy for intermediate- and high-risk prostate cancer: Sign of changing times? JAMA Oncology. American Medical Association. https://doi.org/10.1001/jamaoncol.2016.3987

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free